A Study of HPV Specific Immunotherapy in Subjects With HPV6 Associated Aerodigestive Precancerous Lesions and Malignancies

Trial Profile

A Study of HPV Specific Immunotherapy in Subjects With HPV6 Associated Aerodigestive Precancerous Lesions and Malignancies

Recruiting
Phase of Trial: Phase I

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs INO 3106 (Primary) ; INO 9012 (Primary)
  • Indications Head and neck cancer; Human papillomavirus infections; Lung cancer
  • Focus Adverse reactions
  • Sponsors Inovio Pharmaceuticals
  • Most Recent Events

    • 22 Feb 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Jun 2018 as reported by ClinicalTrials.gov record.
    • 20 Nov 2014 This trial will support an application for orphan drug status, if successful.
    • 23 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top